Breadcrumb
Topic: ExoView Platform for Characterization of Extracellular Vesicles and Viruses
Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results
Preventing hospitalization following COVID-19 infection in vulnerable populations
EDI EventsThe Research Institute of the McGill University Health Centre supports numerous speakers, seminars, and webinars focused on...
Revising our understanding in light of two pandemics
A new study finds mutations affecting the chloride channel of a glutamate transport protein in a rare disorder...
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...
Congratulations to Dr. Patricia Fontela!
Keynote Speaker: Patricia Janet Sime, MD
Topic: From Plants to People
The RI-MUHC senior scientist will present a seminar on “Maternal and child population health...
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...
RI-MUHC researcher is committed to improving the lives of those living with HIV
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
Researchers look to team of astronauts to help answer important questions about chronic pain and sleep
9:00 am to 12:30 pm
A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..
Topic: Cardiovascular research dissemination
On International Women's Day, we asked some of the exceptional members of the RI-MUHC community for their thoughts on...
Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual
World-class neuroradiologist regards her career as “an enormous fortune”
A new study determines the maximum recommended interval between the first and second doses of mRNA...